Navigation Links
Juvaris BioTherapeutics Announces Cooperative Research and Development Agreement With The Centers for Disease Control and Prevention
Date:1/15/2008

al experiments with inactivated virus have shown greater cross-protection when our adjuvant is used."

About Juvaris

Juvaris BioTherapeutics was created in 2003 to develop an immunotherapeutic product platform for the treatment of infectious diseases and cancers using lipid-DNA complexes. Cationic lipids are formulated with non-coding DNA (plasmid) to create the JuvImmune Immunostimulant, a lipid-DNA complex, which as a single product will have utility in multiple infectious disease and cancer applications. The JuvImmune product has been shown to be at least 50-times more potent at triggering innate immune activation and interferon release than current immune stimulants.

When combined with disease-specific antigens, the technology creates JuvaVax vaccines capable of activating substantial antibody- and cell-mediated immune responses, particularly induction of cytotoxic T lymphocytes (CTL). Immunological responses elicited by the lipid-DNA complexes have been successfully demonstrated in both prophylactic and therapeutic settings in a variety of mammals including rodents, rabbits, cats, dogs and non-human primates. This platform provides the opportunity to develop many disease-specific immunotherapy products, for which there are significant unmet medical needs.

The Company recently completed a Series A financing with Kleiner Perkins Caufield & Byers as the sole investor. It plans to start up to four clinical studies in 2008. The first will be a prophylactic vaccine for Influenza A, the second a therapy for chronic Hepatitis B, the third for chronic Hepatitis C and a fourth for Acute Myelogenous Leukemia (AML).

The Company encourages partnering inquiries and can be reached at its website @ http://www.juvaris.com.

Company Contact:

Martin D. Cleary

Juvaris BioTherapeutics, Inc.

925.399.6200

mdcleary@juvaris
'/>"/>

SOURCE Juvaris BioTherapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
2. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Jan. 14, 2014 The Brandeis Medical Center, led by Dr. ... a premier and affordable laser tattoo removal experience with the advanced ... is in providing high quality cosmetic services with cutting edge medical ... " Southern California has seen a dramatic increase ...
(Date:1/14/2014)... , Jan. 14, 2014 Animal Emergency Critical Care, a ... Leesburg, Virginia is the first in ... chamber. Dr. Susan M. Barnes , Medical ... Barnes and husband, Dr. Cole Taylor , are avid scuba ...
(Date:1/14/2014)... Jan. 14, 2014   Oligomerix, Inc. , a privately held ... Alzheimer,s disease (AD) and related neurodegenerative disorders, announced today ... Valhalla, NY as of January 15, 2014 ... New York Medical College. Oligomerix, which is ...
Breaking Medicine Technology:Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2
... 25, 2011 Reportlinker.com announces that a new ... The 2011 Clinical Chemistry ... http://www.reportlinker.com/p0365400/The-2011-Clinical-Chemistry-Market-US-Europe-Japan.html During the ... significant transformation. The changes will be caused by ...
... of gloEMR, gloPM and gloSuite – the only ... management (PM) software with Microsoft Office built right in ... money-back guarantee ensures that doctors will be back up ... their implementation completion date or gloStream will provide a ...
Cached Medicine Technology:Reportlinker Adds The 2011 Clinical Chemistry Market: US, Europe, Japan 2gloStream Success Guarantee Ensures Doctors Will Be Back to Full Patient Load in as Little as 15 Days After EMR Implementation Completion 2gloStream Success Guarantee Ensures Doctors Will Be Back to Full Patient Load in as Little as 15 Days After EMR Implementation Completion 3
(Date:4/17/2014)... Researchers at the University of California, San Diego School ... those who have suffered a recent major loss are ... older adults. , The study is published in this ... Psychiatry . , Because compassionate behaviors are associated with ... findings offer insights into ways to improve the outcomes ...
(Date:4/17/2014)... created a new technology for modifying human cells ... body and selectively target cancer and other sites ... monitor and modify human physiology is a promising ... technology enabled bioengineers to build such devices that ... a customized fashion. , "The project addressed a ...
(Date:4/17/2014)... The cause of neuronal death in Parkinson,s disease is ... may be mistaken for foreign invaders and killed by ... autoimmune diseases like type I diabetes, celiac disease, and ... published April 16, 2014, in Nature Communications . ... in Parkinson,s disease; but if true, it could lead ...
(Date:4/17/2014)... Alliance, a nonprofit organization that focuses on conservation and ... examining the current state of knowledge of the deadly ... global surveillance strategies to combat the emergence of infectious ... West Africa that has claimed the lives of 122 ... According to the World Health Organization (WHO), the deadly ...
(Date:4/17/2014)... Population Council scientists and their partners have found that ... prevent the transmission of multiple sexually transmitted infections (STIs) ... herpes simplex virus 2 (HSV-2), and human papillomavirus (HPV). ... the gel is effective against multiple strains of HIV, ... against all three viruses of at least eight hours ...
Breaking Medicine News(10 mins):Health News:The ilk of human kindness 2Health News:Building 'smart' cell-based therapies 2Health News:Is Parkinson's an autoimmune disease? 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2
... services results in, approximately $1.1 million of annualized expense reduction ... ... International,Inc. (Nasdaq: DATA ), a technology and services company focused ... of its ongoing efforts to maximize operational efficiencies, the,Company will be ...
... MISSISSAUGA, ON, June 17 /PRNewswire-FirstCall/ - Cipher,Pharmaceuticals ... New Drug,Application (NDA) for CIP-TRAMADOL ER, its extended-release ... the U.S. Food and Drug,Administration (FDA). Cipher expects ... In May 2007, the Company received an approvable ...
... BELLEVILLE, ON, June 17 /PRNewswire-FirstCall/ - Bioniche Life ... presented data regarding its E. coli O157:H7,cattle vaccine ... Mikromed 2008,in Belgrade, Serbia last weekend. The presentation ... Health Research & Development., The Bioniche vaccine ...
... NORWALK, Conn., June 17 More than half of ... most common bone disease, according,to the National Osteoporosis Foundation. ... bone loss occurs without symptoms., (Photo: http://www.newscom.com/cgi-bin/prnh/20080415/NYTUFNS1 ... it is often called, is of,particular concern to women, ...
... Clinical Professor of Dermatology at, Columbia University, hair transplant ... ( http://www.bernsteinmedical.com ) in, New York, has been chosen as one ... ... NEW YORK, June 17 Selected for his contributions in ...
... N.J., June 17 Get to soccer practice ...,finish ... of "to do" lists.,It,s no surprise many people have ... Deficit Hyperactivity Disorder (ADHD) too, the,disorder can make it ... ADHD affects 8.7 percent of children in the U.S., ...
Cached Medicine News:Health News:Ease-of-Use and Intuitive Nature of the DATATRAK eClinical(TM) Platform Allows for Further Operational Efficiencies 2Health News:Ease-of-Use and Intuitive Nature of the DATATRAK eClinical(TM) Platform Allows for Further Operational Efficiencies 3Health News:Ease-of-Use and Intuitive Nature of the DATATRAK eClinical(TM) Platform Allows for Further Operational Efficiencies 4Health News:Cipher's revised NDA for CIP-TRAMADOL ER accepted for review by FDA 2Health News:Bioniche Presents E. coli O157:H7 Vaccine Data to International Congress of Medical Microbiology in Serbia 2Health News:Bioniche Presents E. coli O157:H7 Vaccine Data to International Congress of Medical Microbiology in Serbia 3Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Osteoporosis and Bone Health 2Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Osteoporosis and Bone Health 3Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Osteoporosis and Bone Health 4Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Osteoporosis and Bone Health 5Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Osteoporosis and Bone Health 6Health News:Hair Restoration Surgeon named NYC 'Best Doctor' for 9 Years in a Row 2Health News:Organizing Tips for the ADHD Family 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: